National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers
Lists
Only you see this
Abstract
Implementation of these recommendations should encourage optimal use of tumor markers.
BibTeX
@inproceedings{sturgeon2008national,
author = {Catharine M. Sturgeon and Michael J. Duffy and Ulf‐Håkan Stenman and Hans Lilja and Nils Brünner and Daniel W. Chan and Richard J. Babaian and Robert C. Bast and Barry L. Dowell and Francisco J. Esteva and Caj Haglund and Nadia Harbeck and Daniel F. Hayes and Mads Holten-Andersen and George G. Klee and R. Lamerz and Leendert H. J. Looijenga and Rafael Molina and Hans Jørgen Nielsen and Harry G. Rittenhouse and Axel Semjonow and Ie‐Ming Shih and Paul Sibley and György Sölétormos and Carsten Stephan and Lori J. Sokoll and Barry Hoffman and Eleftherios P. Diamandis},
title = {{National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers}},
booktitle = {Clinical},
year = {2008},
doi = {10.1373/clinchem.2008.105601},
}Loading related content...